Enhanced degradation of I-κBα contributes to endogenous activation of NF-κB in Hs294T melanoma cells

Cancer Research

Volumn 57, Issue 14, 1997, Pages 3032-3039

  Shattuck Brandt, Rebecca L ^b   Richmond, Ann ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; DNA; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; PROTEIN INHIBITOR; TRANSCRIPTION FACTOR;

ARTICLE; CARCINOGENESIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN PROCESSING; PROTEIN SYNTHESIS;

DNA-BINDING PROTEINS; HUMANS; I-KAPPA B PROTEINS; MELANOMA; NF-KAPPA B; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030747827     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Richmond, A., Lawson, D. H., and Nixon, D. W. Release of an autostimulatory growth activity by human malignant melanoma cells. Cold Spring Harbor Conf. Cell Proliferation, 9: 885-887, 1982.
2. Richmond, A., and Thomas, H. G. Purification of melanoma growth stimulatory activity. J. Cell. Physiol., 129: 375-384, 1986.
3. Anisowicz., A., Bardwell, L., and Sager, R. Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc. Natl. Acad. Sci. USA, 84: 7188-7192, 1987.
4. Bordoni, R., Fine, R., Murray, D., and Richmond, A. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes. J. Cell. Biochem., 44: 207-219, 1990.
5. Balentien, E., Han, J. H., Thomas, H. G., Wen, D., Samantha, A. K., Zachariae, C. O., Griffin, P. R., Brachmann, R., Wong, W. L., Matsushima, K., Richmond, A., and Derynck, R. Recombinant expression, biochemical characterization, and biological activities of the human MGSA/gro protein. Biochemistry, 29: 10225-10233, 1990.
6. Anisowicz, A., Messineo, M., Lee, S. W., and Sager, R. An NF-κ B-like transcription factor mediates IL-1/TNF-α induction of gro in human fibroblasts. J. Immunol., 147: 520-527, 1991.
7. Shattuck, R. L., Wood, L. D., Jaffe, G. J., and Richmond, A. MGSA/GRO transcription is differentially regulated in normal retinal pigment epithelial and melanoma cells. Mol. Cell. Biol., 14: 791-802, 1994.
8. Haskill, S., Peace, A., Morris, J., Sporn, S. A., Anisowicz, A., Lee, S. W., Smith, T., Martin, G., Ralph, P., and Sager, R. Identification of three related human GRO genes encoding cytokine functions. Proc. Natl. Acad. Sci. USA, 87: 7732-7736, 1990.
9. Baker, N. E., Kucera, G., and Richmond, A. Nucleotide sequence of the human melanoma growth stimulatory activity (MGSA) gene. Nucleic Acids Res., 18: 6453, 1990.
10. Dezube, B. J., Pardee, A. B., Beckett, L. A., Ahlers, C. M., Ecto, L., Allen-Ryan, J., Anisowicz, A., Sager, R., and Crumpacker, C. S. Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-α and its correlation with that of the inflammatory cytokine GRO. J. Acquired Immune Defic. Syndr., 5: 1099-1104, 1992.
11. Rodeck, U., Melber, K., Kath, R., Menssen, H-D., Varello, M., Atkinson, B., and Herlyn, M. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J. Invest. Dermatol., 97: 20-26, 1991.
12. Hosaka, S., Akahoshi, T., Wada, C., and Kondo, H. Expression of the chemokine superfamily in rheumatoid arthritis. Clin. Exp. Immunol., 97: 451-457, 1994.
13. Balentien, E., Mufson, B. E., Shattuck, R. L., Derynck, R., and Richmond, A. Effects of MGSA/GRO α on melanocyte transformation. Oncogene, 6: 1115-1124, 1991.
14. Widmer, U., Manogue, K. R., Cerami, A., and Sherry, B. Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1α, and MIP-1β, members of the chemokine superfamily of proinflammatory cytokines. J. Immunol., 150: 4996-5012, 1993.
15. v-src. Mol. Cell. Biol., 12: 1490-1499, 1992.
16. Baeuerle, P. A., and Baltimore, D. IκB: a specific inhibitor of the NF-κB transcription factor. Science (Washington DC), 242: 540-546, 1988.
17. Miyamoto, S., and Verma, I. M. Rel/NF-κB/IκB story. Adv. Cancer Res., 66: 255-292, 1995.
18. Kopp, E. B., and Ghosh, S. NF-κB and rel proteins in innate immunity. Adv. Immunol, 58: 1-27, 1995.
19. Baeuerle, P. A., Baltimore, D. NF-κB: ten years after. Cell, 87: 13-20, 1996.
20. DiDonato, J., Mercurio, F., Rosette, C., Wu-Li, J., Suyang, H., Ghash, S., and Karin, M. Mapping of the induciblc I-κB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol., 16: 1295-1394, 1996.
21. Chen, Z. J., Parent, I. Matniatis, T. Site-specific phosphorylation of I-κBα by a novel ubiquitination dependent protein kinase activity. Cell, 84: 853-862, 1996.
22. Palombella, V. J., Rando, O. J., Goldberg, A. L., and Maniatis, T. The ubiquitin-proteasome pathway is required for processing the NF-κ B1 precursor protein and the activation of NF-κ B. Cell, 78: 773-785, 1994.
23. Beg, A. A., Ruben, S. M., Scheinman, R. I., Haskill, S., Rosen, C. A., and Baldwin, A. S., Jr. I κ B interacts with the nuclear localization sequences of the subunits of NF-κ B: a mechanism for cytoplasmic retention (published erratum in Genes Dev., 6: 2664-2665, 1992). Genes Dev., 6: 1899-1913, 1992.
24. Ito, C. Y., Kazantsev, A. G., and Baldwin, A. S., Jr. Three NF-κ B sites in the I κ B-α promoter are required for induction of gene expression by TNF α. Nucleic Acids Res., 22: 3787-3792, 1994.
25. De Martin, R., Vanhove, B., Cheng, Q., Hofer, E., Csizmadia, V., Winkler, H., and Bach, F. H. Cytokine-inducible expression in endothelial cells of an IκBα-like gene is regulated by NFκB. EMBO J., 12: 2773-2779, 1993.
26. LeBail, O., Schmidt-Ullrich, R., and Israel, A. Promoter analysis of the gene encoding the IkB-a/MAD3 inhibitor of NF-kB: positive regulation by members of the rel/ NF-kB family. EMBO J., 12: 5043-5049, 1993.
27. Chiao, P. J., Miyamoto, S., and Verma, I. M. Autoregulation of I-kB α activity. Proc. Natl. Acad. Sci. USA, 91: 28-32, 1994.
28. Lombardi, L., Ciana, P., Cappellini, C., Trecca, D., Guerrini, L., Migliazza, A., Maiolo, A. T., and Neri, A. Structural and functional characterization of the promoter regions of the NFKB2 gene. Nucleic Acids Res., 23(12):2328-2336, 1995.
29. Ten, R. M., Paya, C. V., Israel, N., Le Bail, O., Mattei, M. G., Virelizier, J. L., Kourilsky, P., and Israel, A. The characterization of the promoter of the gene encoding the p50 subunit of NF-KB indicates that it participates in its own regulation. EMBO J., 11: 195-203, 1992.
30. Barnes, P. J., and Karin, M. Nuclear Factor-κβ: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 336: 1066-1071, 1997.
31. Sun, S., Ganchi, P. A., Ballard, D. W., and Greene, W. C. NF-κB controls expression of inhibitor I-κBα: evidence for an inducible autoregulatory pathway. Science (Washington DC), 259: 1912-1915, 1993.
32. Zabel, U., and Baeuerle, P. A. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell, 61: 255-265, 1990.
33. Arenzana-Seisdedos, F., Thompson, J., Rodriguez, M. S., Bachelerie, F., Thomas, D., and Hay, R. T. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell. Biol., 15: 2689-2696, 1995.
34. Perez, P., Lira, S. A., and Bravo, R. Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein IκBα. Mol. Cell. Biol., 15: 3523-3530, 1995.
35. Dunn, K. C. Aotaki-Keen, A. E., Putkey, F. R., and Hjelmeland, L. M. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res., 62: 155-169, 1996.
36. Richmond, A., Balentien, E., Thomas, H. G., Flaggs, G., Barton, D. E., Spiess, J., Bordoni, R., Francke, U., and Derynck, R. Molecular characterization of melanoma growth stimulatory activity, a growth factor structurally related to β-thromboglobulin. EMBO J., 7: 2025-2033, 1988.
37. Haskill, S., Beg, A. A., Tompkins, S. M., Morris, J. S., Yurochko, A. D., Sampson-Johannes, A., Mondal, K., Ralph, P., and Baldwin, A. S., Jr. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell, 65: 1281-1289, 1991.
38. Miyamoto, S., Chiao, P. J., and Verma, I. M. Enhanced IκBa degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines. Mol. Cell. Biol., 14: 3276-3282, 1994.
39. Gilmore, T. D., and Morin, P. J. The IκB proteins: members of a multifunctional family. Trends Genet., 9: 427-433, 1993.
40. Rodriguez, M. S., Michalopoulos, I., Arenzana-Seisdedos, F., and Hay, R. T. Inducible degradation of I-κBα in vitro and in vivo requires the acidic C-terminal domain of the protein. Mol. Cell. Biol., 15: 2413-2419, 1995.
41. Schwarz, E. M., van Antwerp, D., and Verma, I. M. Constitutive phosphorylation of I-κBα by casein kinase II occurs preferentially at serine 293: requirement for degradation of free I-κBα. Mol. Cell. Biol., 16: 3554-3559, 1996.
42. Thompson, J. E., Phillips, R. J., Erdjument-Bromage, H., Tempst, P., and Ghosh, S. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell, 80: 573-582, 1995.
43. Weih, F., Lira, S. A., and Bravo, R. Overexpression of RelB in transgenic mice does not affect IκBa levels: differential regulation of RelA and RelB by the inhibitor protein. Oncogene, 12: 445-449, 1996.
44. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., and Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature (Lond.), 376: 167-170, 1995.
45. Beg, A. A., Sha, W. C., Bronson, R. T., and Baltimore, D. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in I-κBα-deficient mice. Genes Dev., 9: 2736-2746, 1995.
46. Klement, J. F., Rice, N. R., Car, B. D., Abbondanzo, S. J., Powers, G. D., Bhatt, H., Chen, C-H., Rosen, C. A., and Stewart, C. L. I-κBα Deficiency Results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol., 16: 2341-2349, 1996.
47. McElhinny, J. A., Trushin, S. A., Bren, G. D., Chester, N., and Paya, C. V. Casein kinase II phosphorylates IκBα at S-283, S-289, S-293, and T-291 and is required for its degradation. Mol. Cell. Biol., 16: 899-906, 1996.
48. Lin, R., Beauparlant, P., Makris, C., Meloche, S., and Hiscott, J. Phosphorylation of I-κB α in the C-terminal PEST domain by casien kinase II affects intrinsic protein stability. Mol. Cell. Biol., 16: 1401-1409, 1996.
49. Tolbert, L. M., and Lameh, J. Human muscarinic cholinergic receptor Hml internalizes via clathrin-coated vesicles. J. Biol. Chem., 271: 17335-17342, 1996.
50. Rice, N. R., and Ernst, M. K. In vivo control of NF-κB activation by IκBα. EMBO J., 12: 4685-4695, 1993.
51. Davis, J. N., Bargmann, W., and Bose, H. R., Jr. Identification of protein complexes containing the c-rel proto-oncogene product in avian hematopoietic cells. Oncogene, 5: 1109-1115, 1990.
52. Hrdlickova, R., Nehyba, J., Roy, A., Humphries, E. H., and Bose, H. R. J. The relocalization of v-Rel from the nucleus to the cytoplasm coincides with induction of expression of Ikba and nfkb1 and stabilization of IκB-α. J. Virol., 69: 403-413, 1995.
53. Houldsworth, J., Mathew, S., Rao, P. H., Dyomina, K., Louie, D. C., Parsa, N., Offit, K., and Chaganti, R. S. K. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood, 87: 25-29, 1996.
54. Neri, A., Chang, C-C., Lombardi, L., Salina, M., Corradini, P., Maiolo, A. T., Chaganti, R. S. K., and Dalla-Favera, R. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell, 67: 1075-1087, 1991.
55. Chang, C. C., Zhang, J., Lombardi, L., Neri, A., and Dalla-Favera, R. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators. Mol. Cell. Biol., 15: 5180-5187, 1995.
56. Fracchiolla, N. S., Lombardi, L., Salina, M., Migliazza, A., Baldini, L., Berti, E., Cro, L., Polli, E., Maiolo, A. T., and Neri, A. Structural alterations of the NF-κB transcription factor lyt-10 in lymphoid malignancies. Oncogene, 8: 2839-2845, 1993.
57. Suzuki, T., Hirai, H., and Yoshida, M. Tax protein of HTLV-1 interacts with the Rel homology domain of NF-κ B p65 and c-Rel proteins bound to the NF-κ B binding site and activates transcription. Oncogene, 9: 3099-3105, 1994.
58. Yamaoka, S., Inoue, H., Sakurai, M., Sugiyama, T., Hazama, M., Yamada, T., and Hatanaka, M. Constitutive activation of NF-κB is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J., 15: 873-887, 1996.
59. Kitajima, I., Shinohara, T., Bilakovics, J., Brown, D. A., Xiao, X., and Nerenberg, M. Ablation of transplanted HTLV-1 Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science (Washington DC), 258: 1792-1795, 1992.
60. Yamada, S., Ikeda, H., Yamazaki, H., Shikishima, H., Kikuchi, K., Wakisaka, A., Kasai, N., Shimotohno, K., and Yoshiki, T. Cytokine-producing mammary carcinomas in transgenic rats carrying the pX gene of human T-lymphotropic virus type I. Cancer Res., 55: 2524-2527, 1995.
61. Beauparlant, P., Kwan, I., Bitar, R., Chou, P., Koromilas, A. E., Sonenberg, N., and Hiscott, J. Disruption of I-κBα regulation by antisense RNA expression leads to malignant transformation. Oncogene, 9: 3189-3197, 1994.
62. Higgins, K. A., Perez, J. R., Coleman, T. A., Dorshkind, K., McComas, W. A., Sarmiento, L. M., Rosen, C. A., and Narayanan, R. Antisense inhibition of the p65 subunit of NF-kB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA, 90: 9901-9905, 1993.